Detection of Carbapenemase Resistance among Clinical Isolates of Escherichia coli

S. Syed Shihaab E Noor; Gopinath P

doi:10.5958/0974-360X.2018.00088.4

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Detection of Carbapenemase Resistance among Clinical Isolates of Escherichia coli

Author(s): S. Syed Shihaab E Noor, Gopinath P

Email(s): Email ID Not Available

DOI: 10.5958/0974-360X.2018.00088.4

Address: S. Syed Shihaab E Noor1, Dr. Gopinath P2
1BDS 2nd Year, Saveetha Dental College, Chennai
2Senior Lecturer, Department of Microbiology, Saveetha Dental College, Chennai
*Corresponding Author

Published In: Volume - 11, Issue - 2, Year - 2018

View HTML

View PDF

ABSTRACT:
Carbapenems have been among the most powerful antibiotics for treating serious infections caused by Gram-negative pathogens, which includes Enterobactericeae, Pseudomonas aeruginosa and Acinetobacter baumannii. We have screened for the antibiotic sensitivity pattern followed by the detection of carbapenemase in our isolates. We found a higher percentage of isolates were shown to be resistant to multiple antibiotics and confirmed to be an multiple drug resistant strains, 15% of isolates were carbapenemase producers. Its ideal to include this test in routine sensitivity pattern in order to rule out the actul mechanism and prompt theapy.

Keywords:

Cite this article:
S. Syed Shihaab E Noor, Gopinath P. Detection of Carbapenemase Resistance among Clinical Isolates of Escherichia coli. Research J. Pharm. and Tech 2018; 11(2): 486-488. doi: 10.5958/0974-360X.2018.00088.4

Cite(Electronic):
S. Syed Shihaab E Noor, Gopinath P. Detection of Carbapenemase Resistance among Clinical Isolates of Escherichia coli. Research J. Pharm. and Tech 2018; 11(2): 486-488. doi: 10.5958/0974-360X.2018.00088.4 Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-2-10